Products Facilities Books & Research Company Links AI Consultation

An honest path,
28 years of integrity.

Founded in 1998.
Still holding the question of pain relief without side effects, AWG ORIGIN® continues its tuning today.

Purpose The founder History Track record Corporate profile

Our purpose

Through integrated technology and information across health, beauty, and medicine,
our purpose is to support everyone who hopes to live a bright life into the future —
conveying what is truly needed, contributing to society, and running our business with integrity.

Toward the exit from the maze called “modern disease”

Today, many people in Japan live with chronic conditions such as cancer, high blood pressure, and diabetes. Once called “diseases of old age,” they became known over time as “adult diseases,” and now, as they appear at younger ages, they have been renamed “modern diseases” or “lifestyle diseases.”

But “modern disease” carries another, harsher definition: an illness that the symptomatic treatment of modern medicine (drugs) alone cannot cure at the root. At the heart of that maze, we pose one question: “Rather than suppressing cells with drugs, could we help them regain their original resonance?” Through an approach that draws on cutting-edge quantum medicine and biological frequencies (QPA), ASIAS works to “tune” the network of life and help guide people toward the exit from the maze.

Tuning — an orthodox, new option

Much of medical practice today centers on “symptomatic treatment” that eases pain and distress. These are, of course, indispensable — a temporary support for getting through hard symptoms.

However, “symptom-suppressing drugs” that lower a fever, lower blood pressure, or take away pain do not remove the root cause of the trouble. In some cases they can even switch off the body’s own natural healing power.

The true “causal therapy” that ASIAS proposes is not about forcing control from the outside with drugs. It is about using specific frequencies (QPA) to unravel the disturbance of information that has arisen in the network between cells (the fascia), and to awaken the body’s inherent capacity to heal on its own. We call this “tuning.”

Addressing the pain at the root of illness.

The AWG ORIGIN® / QPA™ wave-therapy device is designed to resonate with and amplify the causes of pain in the body at a quantum level and work to remove them. ASIAS shares the importance of addressing the pain at the root of illness while also restoring the immune and healing power inherent in the human body, and keeps thinking about what “health” means.

The founder

The late Dr. Masayuki Matsuura, M.D. 1936–2022
The late Dr. Masayuki Matsuura
The late Dr. Masayuki Matsuura
1936.07.18 — 2022.08.31
  • Graduated from the Faculty of Veterinary Medicine, Azabu Veterinary University (1959)
  • A pioneering researcher in frozen-semen and embryo-transfer technology
  • Former Representative Director of Cmex Japan Co., Ltd.
  • Developer of AWG (Arbitrary Waveform Generator)
  • Founder of ASIAS Corp.
July 18, 1936
Born
March 1959
Graduated from the Faculty of Veterinary Medicine, Azabu Veterinary University

From April of that year, began work as a veterinarian at Tochigi Dairy.

April 1963
Opened the Hamamatsu Holstein Hospital and artificial-insemination center

Established as a research base for artificial-insemination technology in cattle. The search for frequencies that protect sperm from viruses and bacteria became the starting point for the later development of AWG ORIGIN® / QPA®.

1969 – early 1970s
Began the research that became the origin of AWG ORIGIN

Within veterinary medicine, began research into “a frequency at which sperm survive but E. coli die.” This became the fundamental question that later developed into AWG (Arbitrary Waveform Generator).

c. 1971 – 1977
Study and observation visits to the US and Canada

Advanced joint research on frozen semen and embryo transfer in cattle and pigs. Also provided technical guidance and conducted experiments in South Korea and Taiwan, building an international research foundation.

June 1978
Founded Cmex Japan Co., Ltd.

Became President and Representative Director. Expanded the business by setting up artificial-insemination centers across Japan, in South Korea, and elsewhere. Succeeded with frozen-sperm artificial-insemination technology and was recognized as a pioneer in the field.

September 2009
Appointed Yasuhiro Nagata as Representative Director

Entrusted management to the next generation and devoted himself to product development and to the research and business activities aimed at expanding overseas. He poured his energy into spreading AWG ORIGIN technology until his final years.

Dr. Masayuki Matsuura and Yasuhiro Nagata (2010)
Masayuki Matsuura and Yasuhiro Nagata (April 2010)
December 2015
Awarded an honorary doctorate of medicine and honorary membership by the International Royal Academy of the United Nations

The INTERNATIONAL ROYAL ACADEMY OF THE UNITED NATIONS (IRAUN) selected and honored him as an Honored Doctor of Medicine in recognition of his substantial contributions to medicine, education, and culture. He was also recognized as an honorary member of the Royal Heritage Academy.

Honorary member, Royal Heritage Academy / Honored Doctor of Medicine (IRAUN), 2015
August 31, 2022
Passed away

At the age of 86. His will lives on in the AWG ORIGIN® / QPA® technology and in the work of the Matrix Integrative Medicine Research Association (MIMRA).

The path ahead
Carrying the philosophy forward

Carrying frozen-semen and embryo-transfer technology, Masayuki Matsuura traveled the livestock sites of South Korea and Taiwan and built a foundation of trust on the ground. Just as momentum was building — a sense that “the real work starts now” — a collaborator died suddenly amid political upheaval, followed by the death of the factory manager who had helped support product development in Japan. The two losses shook the foundations of the business, but Matsuura did not stop. He continued his research even as he lost his sight, and passed the core of the technology to the next generation — from “Dr. Hi-Ezex” to “AWG ORIGIN®.” With legal compliance as its foundation, ASIAS Corp. will honestly carry the question its developer kept asking, for the good of society and its people.

History

Phase 1–2 / Founding & adoption
May 1, 1998
Yukio Funai (ed.), Discovering the “Fifth Force”

Introduced as “Dr. Hi-Ezex.” Drew attention as a form of advanced medicine that physically destroys viruses and bacteria.

November 10, 1998
ASIAS Corp. founded

Renamed from “Dr. Hiexex.” Began selling the “AC series” of low-frequency therapy devices.

May 2003
Yasuhiro Nagata, the current representative, joins the company
April 2018
Current “AC5000 series” goes on sale
March 2021
Current portable model “AC6000” goes on sale
Phase 3–4 / Research & MIMRA phase
From January 2021
Case research on fibromyalgia begins at a university
From July 2022
Research collaboration with Chiba University begins

Commissioned research using AWG ORIGIN® / QPA®.

From July 2023
Participates in the Endowed Course for Pain Medicine Development at Aichi Medical University
October 28, 2023
1st AWG ORIGIN® symposium of the Endowed Course for Pain Medicine Development

At Aichi Medical University

June 2024
Matrix Integrative Medicine Research Association (MIMRA), a general incorporated association, is established
September 2024
English paper published in the Chiba Medical Journal

“A consideration of the lifestyle-disease-prevention effects of a low-frequency therapy device” (Chiba Med. J. 100E: 39–48, 2024)

December 2024
Presentation at the luncheon seminar of the 28th Congress of the Japanese Society for Integrative Medicine
January 2025
2nd symposium of the Endowed Course for Pain Medicine Development
December 2025
Presentation at the luncheon seminar of the 29th Congress of the Japanese Society for Integrative Medicine

“How AWG ORIGIN® works to balance the dynamic equilibrium of the fascia”

Date Item Author / outlet
2004/09 Cancer Can Be Cured with Abo’s Immunology and Ueno-Style Alternative Medicine (in Japanese) Toru Abo & Hiroiku Ueno
2008 [Society journal] Ayurveda Research No. 38, 39 Kazui Hoshi
2009/03 [Society journal] Overcoming Cancer with Integrative Medicine vol. 9 Japanese oncology society (ed.)
2011/12 “AWG”: Magic or Medicine? (revised ed., in Japanese) Masaki Toshinari
2013/12 [Society journal] Journal of the Psi Society vol. 35 — The World of Dark-Field Microscopy Taiji Ujihashi
2014/01 Wake Up! The Patient Revolution (in Japanese) Katsunari Nishihara
2014/09 Progress in Cancer Immunotherapy Will Save Japan (in Japanese) Kihachiro Takahara
2017/03 The Secret Frequency at Which Somatids Burst with Joy (in Japanese) Taiji Ujihashi
2018/10 [Medical paper, J-GLOBAL] Cancer pain treatment using an AWG treatment device Toru Fujita
2019/03 Why Does Treatment for Intractable Diseases Fail? (in Japanese) Toru Fujita
2020/12 The Birth of Quantum Medicine (in Japanese) — first use of the name “QPA” Kunio Yasue & Masanori Kobayashi
2023/01 The Magic Frequency: AWG ORIGIN® (in Japanese) Hikaruland editorial team
2024/09 [Peer-reviewed paper] Chiba Med. J. 100E: 39–48 Chiba University
2025/12 Why Does Pain Disappear When the “Fascia” Resonates?! (in Japanese) Hiroto Koike

Track record

4,000
Patients
Cumulative rental users
26
Facilities
Facilities using it across Japan
28
Years
Years since founding

Corporate profile

About ASIAS Corp.

ASIAS Corp. is the company that officially provides information on AWG ORIGIN® / QPA® — related books, technical explanations, and information about the facilities that use it. Beyond product information, our official site also organizes and publishes related books, technical explanations, facility introductions, and company information.

Company name ASIAS Corp.
Kabushiki Kaisha ASIAS
Founded 1998
Address Hamakita Chuo Bldg. 301
150-1 Numa, Hamana-ku, Hamamatsu-shi
Shizuoka 434-0037, Japan
TEL +81-53-424-8888
Contact Inquiry form (English inquiries welcome)
Capital JPY 20 million
Representative Director Yasuhiro Nagata
Business hours 9:00–17:00 (JST)
(Closed Saturdays, Sundays, public holidays, and during summer and year-end periods)
License License for the sale and lease of highly controlled medical devices
Hamaken Hama-A No. 11-820
License for the sale and lease of highly controlled medical devices
Click to enlarge

Business activities

  • Development, design, sale, and lease of medical devices and scientific instruments
  • Manufacture and sale of pharmaceuticals, quasi-drugs, cosmetics, dietary supplements, and food additives
  • Contracted operation, management, and maintenance of treatment facilities (hospitals, massage, acupuncture and moxibustion, and manual therapy), health-training facilities, and health-checkup facilities
Contact us

Feel free to reach out about introduction consultations, product questions, press enquiries, or academic collaboration.

The representative and their background

We publish, to the extent it can be made public, the representative’s background, related qualifications, awards, and course-completion certificates. These are reference materials for understanding how ASIAS came to do this work and the background to its information activities on AWG ORIGIN® / QPA®.

Public documents & certificates

The materials below are an organized set of certificates, awards, and course-completion certificates that can be made public. Each is provided as a reference for confirming the background of ASIAS’s work and the representative’s career.

International Life Science Association
certificate
2007
↗ Open in a new tab
Industrial Counselor
examination pass certificate
2013
↗ Open in a new tab
METATRON SAKURA diploma
METATRON® SAKURA
diploma
2017
↗ Open in a new tab
Higashikuni-no-miya Award
(Peace, Culture, and Commemorative — 3 awards)
2017–2018
↗ Open in a new tab
Osaka University MEI Center
Medical Device
Design Course — completed
2022
↗ Open in a new tab